Skip to main content
Clinical Trials/CTRI/2020/05/025430
CTRI/2020/05/025430
Not yet recruiting
Phase 1

A Cross Sectional Study To Observe The Health Status Of Personnels Engaged In Care Of Covid-19 Infected/Suspected Persons And Receiving Ayurveda Immuno-Modulator Drugs In Jodhpur City - CSOSC

Dabur India Ltd0 sites0 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Dabur India Ltd
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • Person deployed in quarentine ward
  • Person on hard duty
  • family members of health care personnel
  • willingness to participate in study
  • Taking Ayurveda immunomodulator drugs ( Tab. Maha Sudarshan vati \+ Tab Samshamani Vati \+ Tab. Haridra

Exclusion Criteria

  • Person below 18 yrs \& above 65 yrs
  • Preganant women
  • Any medical condition for which the person is recieing any immunosupressive medicine
  • Known case of malignancy

Outcomes

Primary Outcomes

Not specified

Similar Trials